WCBA
ELV icon

Weaver C. Barksdale & Associates’s Elevance Health ELV Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.11M Sell
5,451
-18
-0.3% -$6.67K 1.89% 21
2026
Q1 		$1.6M Buy
5,469
+336
+7% +$110K 1.53% 42
2025
Q4 		$1.8M Buy
5,133
+757
+17% +$256K 1.89% 21
2025
Q3 		$1.41M Sell
4,376
-278
-6% -$86.5K 1.36% 43
2025
Q2 		$1.81M Sell
4,654
-39
-0.8% -$15.7K 1.73% 30
2025
Q1 		$2.04M Sell
4,693
-110
-2% -$44.2K 1.96% 16
2024
Q4 		$1.77M Buy
+4,803
New +$2.01M 1.7% 28

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Weaver C. Barksdale & Associates's ELV Position: Q2 2026 in Review

Weaver C. Barksdale & Associates reduced its Elevance Health (ELV) stake by 0.33% in Q2 2026, selling an estimated $6.67K and leaving 5,451 shares worth $2.11M. The position accounts for 1.89% of the portfolio, ranked #21.

Weaver C. Barksdale & Associates first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Weaver C. Barksdale & Associates held 5,451 shares of Elevance Health worth $2.11M as of Q2 2026.
  • Weaver C. Barksdale & Associates sold 18 Elevance Health shares in Q2 2026, an estimated $6.67K.
  • Elevance Health made up 1.89% of Weaver C. Barksdale & Associates's portfolio in Q2 2026, its #21 holding.
  • Weaver C. Barksdale & Associates first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Weaver C. Barksdale & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.